EPISODE · Jan 9, 2020 · 6 MIN
HT VTE Risk by Route of Administration.
from Dr. Chapa’s OBGYN Clinical Pearls · host Dr. Chapa’s Clinical Pearls
Most studies on the risks of post menopausal hormone therapy have focused on the oral route of administration. Does the transdermal route of estrogen delivery reduce the risk of VTE? In this episode, we will review the ACOG committee opinion (556) and ASRM guidelines on the use of transdermal estrogen vs oral estrogen therapy.
Embed this episode
NOW PLAYING
HT VTE Risk by Route of Administration.
0:00
6:03
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Dr. Chapa’s OBGYN Clinical Pearls?
This episode is 6 minutes long.
When was this Dr. Chapa’s OBGYN Clinical Pearls episode published?
This episode was published on January 9, 2020.
Can I download this Dr. Chapa’s OBGYN Clinical Pearls episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!